GILD
NASDAQStockGilead Sciences, Inc.
$146.44+0.45 (+0.31%)
52-Week Range
$96.91
$155.80
Key Stats
Market Cap
181.8B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.37
Volume
3.5M
Avg Volume
6.7M
Performance
1M
-0.84%
3M
+21.26%
6M
+29.73%
YTD
+20.07%
1Y
+28.08%
3Y
+83.62%
5Y
+131.49%
Price Chart
ETF Exposure
GILD is held by 481 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| BBH | VanEck Biotech ETF | 17.09% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 9.76% |
| IBB | iShares Biotechnology ETF | 9.62% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 6.64% |
| QQQA | ProShares - Nasdaq-100 Dorsey Wright Momentum ETF | 5.76% |
| TERM | EquityCompass Tactical Risk Manager ETF | 5.66% |
| PBE | Invesco Biotechnology & Genome ETF | 5.28% |
| PJP | Invesco Pharmaceuticals ETF | 5.28% |
| WBIY | WBI Power Factor High Dividend ETF | 4.79% |
| TBXU | Direxion Daily Biotech Top 5 Bull 2X ETF | 4.47% |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 4.38% |
| BAMD | Brookstone Dividend Stock ETF | 4.24% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 3.85% |
| PINK | Simplify Health Care ETF | 3.79% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 3.75% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 3.67% |
| SIXH | ETC 6 Meridian Hedged Equity Index Option ETF | 3.66% |
| CNCR | Loncar Cancer Immunotherapy ETF | 3.33% |
| XLV | State Street Health Care Select Sector SPDR ETF | 3.33% |
| BMED | iShares Health Innovation Active ETF | 3.31% |
| VLLU | Harbor AlphaEdge Large Cap Value ETF (VLLU) | 3.21% |
| LGCF | Themes US Cash Flow Champions ETF | 3.20% |
| IYH | iShares U.S. Healthcare ETF | 3.18% |
| USCF | Themes US Cash Flow Champions ETF | 2.88% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 2.85% |
| WBIL | WBI BullBear Quality 3000 ETF | 2.82% |
| RND | First Trust Bloomberg R&D Leaders ETF | 2.79% |
| JPEF | JPMorgan Equity Focus ETF | 2.73% |
| WBIG | WBI BullBear Yield 3000 ETF | 2.71% |
| SPHQ | Invesco S&P 500 Quality ETF | 2.69% |
| VHT | Vanguard Health Care ETF | 2.68% |
| UDI | USCF ESG Dividend Income Fund | 2.63% |
| QQEW | First Trust Nasdaq-100 Select Equal Weight ETF | 2.62% |
| DURA | VanEck Durable High Dividend ETF | 2.59% |
| TOLL | Tema Durable Quality ETF | 2.56% |
| RXL | ProShares - Ultra Health Care | 2.47% |
| FTCS | First Trust Capital Strength ETF | 2.38% |
| GNOM | Global X - Genomics & Biotechnology ETF | 2.34% |
| IXJ | iShares Global Healthcare ETF | 2.33% |
| HDV | iShares Core High Dividend ETF | 2.29% |
| VMAX | Hartford US Value ETF | 2.28% |
| QVMT | Invesco S&P 500 Concentrated QVM ETF | 2.22% |
| LOWV | Alliance Bernstein - AB US Low Volatility Equity ETF | 2.21% |
| DFTT | DF Tactical 30 ETF | 2.20% |
| ABFL | Abacus FCF Leaders ETF | 2.16% |
| QDIV | Global X - S&P 500 Quality Dividend ETF | 2.11% |
| QQXT | First Trust NASDAQ-100 Ex-Technology Sector Index Fund | 2.10% |
| DEFN | Emles Trust - Emles Protective Allocation ETF | 2.06% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 2.06% |
| RYH | Invesco S&P 500 Equal Weight Health Care ETF | 2.06% |
Page 1 of 10Next
About GILD ETF Exposure
Gilead Sciences, Inc. (GILD) is held by 481 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 181.8B, GILD is a widely held institutional stock. The stock currently trades at $146.44. Investors can gain exposure to GILD through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold GILD, sorted by portfolio weight.